Product Details
Clavulin (BID)
Amoxicillin + Clavulanic Acid400 mg + 57 mg/5 mL
Powder for Oral Suspension
DIN/PIN/NPN
02238830
Manufacturer
GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care
Formulary Listing Date
2000-01-17
Unit Price
0.3571
Amount MOH Pays
0.1591
Coverage Status
General Benefit
ODB Formulary Therapeutic Classification
Therapeutic Note
Amoxicillin + Clavulanic Acid: Amoxicillin/clavulanic acid is not recommended as first line treatment for acute otitis media and sinusitis. Antibiotic resistance (H. influenzae, M. catarrhalis) due to B-lactamase production has caused only a minority of treatment failures with amoxicillin. Amoxicillin/clavulanic acid is first line treatment for infected bites of cat, dog or human.
ATC Code
J01CR02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02238830 | Clavulin (BID) | 0.3571 | 0.1591 |
| 02530694 | M-Amoxi Clav | 0.1591 | 0.1591 |
| 02539446 | Jamp Amoxi Clav Suspension | 0.1591 | 0.1591 |